BinuA, KumarSS, PadmaUD, et al.Pathophysiological basis in the management of myasthenia gravis: A mini review. Inflammopharmacology, 2022; 30:61–71; doi: 10.1007/s10787-021-00905-9
2.
Mané-DamasM, MolenaarPC, UlrichtsP, et al.Novel treatment strategies for acetylcholine receptor antibody-positive myasthenia gravis and related disorders. Autoimmun Rev, 2022; 21:103104; doi: 10.1016/j.autrev.2022.103104
3.
RodriguesCL, de FreitasHC, LimaPRO, et al.Myasthenia gravis exacerbation and myasthenic crisis associated with COVID-19: Case series and literature review. Neurol Sci, 2022; 43:2271–2276; doi: 10.1007/s10072-021-05823-w
4.
SansoneG, BonifatiDM. Vaccines and myasthenia gravis: A comprehensive review and retrospective study of SARS-CoV-2 vaccination in a large cohort of myasthenic patients. J Neurol, 2022; 269:3965–3981; doi: 10.1007/s00415-022-11140-9
5.
AlcantaraM, BarnettC, KatzbergH, et al.An update on the use of immunoglobulins as treatment for myasthenia gravis. Expert Rev Clin Immunol, 2022; 18:703–715; doi: 10.1080/1744666x.2022.2084074
